Peter V
Tuesday, April 7, 2026
31.9
C
Bengaluru
Hot topics
Pharma in the New Normal
2020 has been a challenging year for all industries. For pharma and its HCP customers even more so. All eyes are on the companies developing vaccines and drugs for treatment of COVID-19, while doctors have closed their doors for pharma reps. Long established processes have been disrupted and complex market strategies have been rendered useless. Each pharma no matter big or small, innovative, or generic, had to improvise and come up with contingency plans to save the year. Some have been slower waiting for the old ways to come back, others have been more agile experimenting with digital and expanding boundaries, most are in the middle digitally curious but not risking too much.
The Rise and Fall of Core Parenterals – India’s IV Fluid Pioneer
Background
Core Healthcare Ltd., popularly known as Core Parenterals, was...
The ‘Amazonization’ of Healthcare
Inside this Issue
1. The 'Amazonization' of Healthcare by Salil Kallianpur
Amazon's drive...
Orphan Drugs and Indian Pharma: Moving from Volume to Value?
Zydus’ ZYCUBO May Be the Proof Point the Industry...
From Collapse to Catalyst: Orchid Pharma’s Innovation-Led Phoenix Rise and the AMR Challenge
Opening Frame: The "Silent" Pandemic Meets Strategic Grit
In the...
Oracle Debacle – Midlife Reinvention is an Al Generated Orwellian Lie
A Tale of Two Truths: Severance, Up in the...
Sachhin Misshra has been elevated to the role of President at Akumentis Healthcare.
Sachhin Misshra has been elevated to the role of...
Hype and Happening: GLP-1 Growth Story – Follow the Patient, not the Primary Sales
Is Obesity (Drugs) Masking Underlying (Metabolic) Risk Factors in...
Trump’s 100% Drug Tariffs Explained: The Surprising Opportunity for India
How the 2026 U.S. tariff action on branded drugs...
From Collapse to Catalyst: Orchid Pharma’s Innovation-Led Phoenix Rise and the AMR Challenge
Opening Frame: The "Silent" Pandemic Meets Strategic Grit
In the...
Oracle Debacle – Midlife Reinvention is an Al Generated Orwellian Lie
A Tale of Two Truths: Severance, Up in the...
Sachhin Misshra has been elevated to the role of President at Akumentis Healthcare.
Sachhin Misshra has been elevated to the role of...
Hype and Happening: GLP-1 Growth Story – Follow the Patient, not the Primary Sales
Is Obesity (Drugs) Masking Underlying (Metabolic) Risk Factors in...
Trump’s 100% Drug Tariffs Explained: The Surprising Opportunity for India
How the 2026 U.S. tariff action on branded drugs...
From Collapse to Catalyst: Orchid Pharma’s Innovation-Led Phoenix Rise and the AMR Challenge
Opening Frame: The "Silent" Pandemic Meets Strategic Grit
In the...
Oracle Debacle – Midlife Reinvention is an Al Generated Orwellian Lie
A Tale of Two Truths: Severance, Up in the...
Sachhin Misshra has been elevated to the role of President at Akumentis Healthcare.
Sachhin Misshra has been elevated to the role of...
Hype and Happening: GLP-1 Growth Story – Follow the Patient, not the Primary Sales
Is Obesity (Drugs) Masking Underlying (Metabolic) Risk Factors in...
Trump’s 100% Drug Tariffs Explained: The Surprising Opportunity for India
How the 2026 U.S. tariff action on branded drugs...
From Collapse to Catalyst: Orchid Pharma’s Innovation-Led Phoenix Rise and the AMR Challenge
Opening Frame: The "Silent" Pandemic Meets Strategic Grit
In the...
Oracle Debacle – Midlife Reinvention is an Al Generated Orwellian Lie
A Tale of Two Truths: Severance, Up in the...
Sachhin Misshra has been elevated to the role of President at Akumentis Healthcare.
Sachhin Misshra has been elevated to the role of...
Hype and Happening: GLP-1 Growth Story – Follow the Patient, not the Primary Sales
Is Obesity (Drugs) Masking Underlying (Metabolic) Risk Factors in...
Trump’s 100% Drug Tariffs Explained: The Surprising Opportunity for India
How the 2026 U.S. tariff action on branded drugs...
Hot topics
Pharma CEO Roundtable on 27th October 2021
Engaging Doctors – Physical, Digital & Hybrid: Translating Strategy...
Pharma Digital Transformation – Leadership challenges
“Real digital transformation occurs when courageous leaders align goals...
FieldForce Is Not Your Frontline Anymore. Meet the New Force in Healthcare
When drones first appeared on battlefields, military establishments reacted...
The Antifungal Blind Spot: India’s Quiet Clinical Crisis
A market analysis and clinical commentary on the growing...
Are Digital Pharmacies a Game Changer?
Lower prices, discounts, convenience of ordering and home delivery are some of the benefits for consumers with e-pharmacies. The anonymity of the internet encourages patients to seek information about medicines that they would otherwise avoid. Mental health is one area where the consumers wish to maintain confidentiality and opt for online consultation and medication.
From Collapse to Catalyst: Orchid Pharma’s Innovation-Led Phoenix Rise and the AMR Challenge
Opening Frame: The "Silent" Pandemic Meets Strategic Grit
In the...
Oracle Debacle – Midlife Reinvention is an Al Generated Orwellian Lie
A Tale of Two Truths: Severance, Up in the...
Sachhin Misshra has been elevated to the role of President at Akumentis Healthcare.
Sachhin Misshra has been elevated to the role of...
Hype and Happening: GLP-1 Growth Story – Follow the Patient, not the Primary Sales
Is Obesity (Drugs) Masking Underlying (Metabolic) Risk Factors in...
Trump’s 100% Drug Tariffs Explained: The Surprising Opportunity for India
How the 2026 U.S. tariff action on branded drugs...
From Collapse to Catalyst: Orchid Pharma’s Innovation-Led Phoenix Rise and the AMR Challenge
Opening Frame: The "Silent" Pandemic Meets Strategic Grit
In the...
Oracle Debacle – Midlife Reinvention is an Al Generated Orwellian Lie
A Tale of Two Truths: Severance, Up in the...
Sachhin Misshra has been elevated to the role of President at Akumentis Healthcare.
Sachhin Misshra has been elevated to the role of...
Hype and Happening: GLP-1 Growth Story – Follow the Patient, not the Primary Sales
Is Obesity (Drugs) Masking Underlying (Metabolic) Risk Factors in...
Trump’s 100% Drug Tariffs Explained: The Surprising Opportunity for India
How the 2026 U.S. tariff action on branded drugs...
From Collapse to Catalyst: Orchid Pharma’s Innovation-Led Phoenix Rise and the AMR Challenge
Opening Frame: The "Silent" Pandemic Meets Strategic Grit
In the...
Oracle Debacle – Midlife Reinvention is an Al Generated Orwellian Lie
A Tale of Two Truths: Severance, Up in the...
Sachhin Misshra has been elevated to the role of President at Akumentis Healthcare.
Sachhin Misshra has been elevated to the role of...
Hype and Happening: GLP-1 Growth Story – Follow the Patient, not the Primary Sales
Is Obesity (Drugs) Masking Underlying (Metabolic) Risk Factors in...
Trump’s 100% Drug Tariffs Explained: The Surprising Opportunity for India
How the 2026 U.S. tariff action on branded drugs...
From Collapse to Catalyst: Orchid Pharma’s Innovation-Led Phoenix Rise and the AMR Challenge
Opening Frame: The "Silent" Pandemic Meets Strategic Grit
In the...
Oracle Debacle – Midlife Reinvention is an Al Generated Orwellian Lie
A Tale of Two Truths: Severance, Up in the...
Sachhin Misshra has been elevated to the role of President at Akumentis Healthcare.
Sachhin Misshra has been elevated to the role of...
Hype and Happening: GLP-1 Growth Story – Follow the Patient, not the Primary Sales
Is Obesity (Drugs) Masking Underlying (Metabolic) Risk Factors in...
Trump’s 100% Drug Tariffs Explained: The Surprising Opportunity for India
How the 2026 U.S. tariff action on branded drugs...
MedicinMan was launched in 2011 as India’s 1st Magazine dedicated to the cause of Field Force Excellence in Pharma and Devices.
Read More
Headlines
From Collapse to Catalyst: Orchid Pharma’s Innovation-Led Phoenix Rise and the AMR Challenge
Opening Frame: The "Silent" Pandemic Meets Strategic Grit
In the...
Oracle Debacle – Midlife Reinvention is an Al Generated Orwellian Lie
A Tale of Two Truths: Severance, Up in the...
Sachhin Misshra has been elevated to the role of President at Akumentis Healthcare.
Sachhin Misshra has been elevated to the role of...
Hype and Happening: GLP-1 Growth Story – Follow the Patient, not the Primary Sales
Is Obesity (Drugs) Masking Underlying (Metabolic) Risk Factors in...
Newsletter
Get important news delivered directly to your inbox and stay connected!